Physical Description
White to light yellow powder
Solubility (5% in water)
Clear, colourless to faint yellow solution
Specification Version
1.0
Hazard statements
H302: Harmful if swallowed.
H315: Causes skin irritation.
H319: Causes serious eye irritation.
H332: Harmful if inhaled.
H335: May cause respiratory irritation.
H350: May cause cancer.
Precautionary statements
P201: Obtain special instructions before use.
P261: Avoid breathing dust/fume/gas/mist/vapours/spray.
P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
P302 + P352: IF ON SKIN: Wash with plenty of soap and water.
P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P310: Immediately call a POISON CENTER or doctor/physician.
P308 + P313: IF exposed or concerned: Get medical advice/attention.
UN Number
UN2811 - 6.1 - PG II
If you are publishing research using GA1776 please
contact us to contribute to our list of citations.
Hydrogel implants for transscleral drug delivery for retinoblastoma treatment
Ana-Irina Cocarta, Radka Hobzova, Jakub Sirc, Tereza Cerna, Jan Hrabeta, Karel Svojgr, Pavel Pochop, Martina Kodetova, Jarmila Jedelska, Udo Bakowsky, Jiri Uhlik
Materials Science and Engineering: C, 109799, 103 (2019)
Retinoblastoma (Rb) is the most common primary malignant intraocular tumor in children which develops from the retinal stem cells. Systemic chemotherapy is the typical therapeutic treatment and though most children survive Rb, they often lose their vision, or the eye needs to be enucleated. Regardi…
read more
Australia
Austria
Belgium
Canada
Czech Republic
Denmark
France
Germany
Greece
Hungary
Ireland
Israel
Italy
Japan
Korea South
Netherlands
New Zealand
Norway
Poland
Portugal
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
United Kingdom
United States
Vietnam
